← Back to Patent Explorer
US5324647A Expired / Lapsed US ⏱️ 0.0 years remaining

Fibrin coated polymer surfaces

Assignee: McMaster University
•
Filing: 1993-09-14
•
Granted: 1994-06-28
•
Expires: 2013-09-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Surfaces of polymeric materials are coated with a layer of thermally denatured fibrinogen. The fibrinogen may be treated with thrombin to produce fibrin, and additional fibrinogen and factor XIII added to produce a cross-linked fibrin coating. The resulting coated surface is stable, anti-thrombotic and resistant to platelet adhesion. Polymeric materials coated in this way are useful in constructing vascular grafts and prosthetic devices, and provide test systems useful in the study of thrombogenesis.

Inventors

  • 👤 Fraser D. Rubens
  • 👤 Paul D. Bishop

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 03:03
CPC Classifications
A; A61; A61L; A61L33/00; A61L33/06; A61L33/12; A61L33/126; A61L27/00; A61L27/28; A61L27/34; Y; Y10; Y10T; Y10T436/00; Y10T436/10

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 82 words
In a method of coating a surface of a polymeric material with fibrin, the improvement comprising: incubating said polymeric material in a solution of fibrinogen at a temperature of at least 56° C. but less than 100° C. to produce a fibrinogen-coated surface; treating the fibrinogen-coated surface with thrombin to produce fibrin monomers; and then exposing the thrombin-treated surface to a solution comprising factor XIII and additional fibrinogen, whereby the additional fibrinogen is converted to fibrin and cross-linked to the fibrin-coated surface.
Claim 2
Dependent Claim 82 words
In a method of coating a surface of a polymeric material with fibrin, the improvement comprising: incubating said polymeric material in a solution of fibrinogen at a temperature of at least 56° C. but less than 100° C. to produce a fibrinogen-coated surface; treating the fibrinogen-coated surface with thrombin to produce fibrin monomers; and then exposing the thrombin-treated surface to a solution comprising factor XIII and additional fibrinogen, whereby the additional fibrinogen is converted to fibrin and cross-linked to the fibrin-coated surface.
Claim 3
Dependent Claim 24 words
A method according to claim 1 wherein the factor XIII concentration in the solution comprising factor XIII and additional fibrinogen is from 0.25-20 μg/mL.
Claim 4
Dependent Claim 24 words
A method according to claim 1 wherein the factor XIII concentration in the solution comprising factor XIII and additional fibrinogen is from 0.25-5.0 μg/mL.
Claim 5
Dependent Claim 23 words
A method according to claim 1 wherein the fibrinogen concentration in the solution comprising factor XIII and additional fibrinogen is from 0.5-5.0 mg/mL.
Claim 6
Dependent Claim 36 words
A method according to claim 1 wherein said solution comprising factor XIII and additional fibrinogen further comprises basic fibroblast growth factor, endothelial cell growth factor, α 2 macroglobulin, vitronectin, fibronectin, or a cell-binding fragment of fibronectin.
Claim 7
Dependent Claim 18 words
A method according to claim 1 wherein said solution comprising factor XIII and additional fibrinogen comprises endothelial cells.
Claim 8
Dependent Claim 18 words
A method according to claim 1 further comprising the step of seeding the cross-linked fibrin with endothelial cells.
Claim 9
Dependent Claim 11 words
A polymeric material prepared according to the method of claim 1.
Claim 10
Dependent Claim 36 words
A polymeric material prepared according to the method of incubating said polymeric material in a solution of fibrinogen at a temperature of at least 56° C. but less than 100° C. to produce a fibrinogen-coated surface.
Claim 11
Dependent Claim 36 words
A polymeric material prepared according to the method of incubating said polymeric material in a solution of fibrinogen at a temperature of at least 56° C. but less than 100° C. to produce a fibrinogen-coated surface.
Claim 12
Dependent Claim 48 words
A polymeric material prepared according to the method of: incubating said polymeric material in a solution of fibrinogen at a temperature of at least 56° C. but less than 100° C. to produce a fibrinogen-coated surface; and then treating the fibrinogen-coated surface with thrombin to produce fibrinogen monomers.
Claim 13
Dependent Claim 48 words
A polymeric material prepared according to the method of: incubating said polymeric material in a solution of fibrinogen at a temperature of at least 56° C. but less than 100° C. to produce a fibrinogen-coated surface; and then treating the fibrinogen-coated surface with thrombin to produce fibrinogen monomers.

References Cited (Backward Citations)

US4167045A Cited
US4273873A Cited
US4534069A Cited
US4627879A Cited
US5230693A Cited
US5266476A Cited
EP0290462A1 Cited
US5131907A Cited
EP0366564A2 Cited
US5171261A Cited
WO1991016009A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-06-27 1997-12-27 1998-06-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-06-27 2001-12-27 2002-06-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-06-27 2005-12-27 2006-06-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag